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Abstract
We have previously demonstrated that clock genes contribute to the homeostatic aspect of sleep regulation. Indeed,
mutations in some clock genes modify the markers of sleep homeostasis and an increase in homeostatic sleep drive alters
clock gene expression in the forebrain. Here, we investigate a possible mechanism by which sleep deprivation (SD) could
alter clock gene expression by quantifying DNA-binding of the core-clock transcription factors CLOCK, NPAS2, and BMAL1
to the cis-regulatory sequences of target clock genes in mice. Using chromatin immunoprecipitation (ChIP), we first showed
that, as reported for the liver, DNA-binding of CLOCK and BMAL1 to target clock genes changes in function of time-of-day in
the cerebral cortex. Tissue extracts were collected at ZT0 (light onset), 26, 212, and 218, and DNA enrichment of E-box or
E’-box containing sequences was measured by qPCR. CLOCK and BMAL1 binding to Cry1, Dbp, Per1, and Per2 depended on
time-of-day, with maximum values reached at around ZT6. We then observed that SD, performed between ZT0 and 26,
significantly decreased DNA-binding of CLOCK and BMAL1 to Dbp, consistent with the observed decrease in Dbp mRNA
levels after SD. The DNA-binding of NPAS2 and BMAL1 to Per2 was also decreased by SD, although SD is known to increase
Per2 expression in the cortex. DNA-binding to Per1 and Cry1 was not affected by SD. Our results show that the sleep-wake
history can affect the clock molecular machinery directly at the level of chromatin binding thereby altering the cortical
expression of Dbp and Per2 and likely other targets. Although the precise dynamics of the relationship between DNA-
binding and mRNA expression, especially for Per2, remains elusive, the results also suggest that part of the reported
circadian changes in DNA-binding of core clock components in tissues peripheral to the suprachiasmatic nuclei could, in
fact, be sleep-wake driven.
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Introduction
Sleep loss has a profound, negative impact on cognition,
learning, mood, and diverse aspects of mental health [1]. Although
chronic sleep debt is a growing problem in our society, the
molecular and cellular sources of its deleterious effects remain
poorly understood. Sleep is known to be regulated by the tight
interaction between two main processes [2,3]: a sleep homeostat
that tracks sleep need according to the duration of time spent
awake and asleep, and a circadian timing system that determines
the propensity for wakefulness according to an about 24 h rhythm.
At the molecular level, the regulation of the circadian timing
system has been extensively studied and it is now well-established
that circadian rhythms originate from interacting transcriptional-
translational feedback loops involving clock genes and their
protein products [4]. In contrast, the molecular wiring of the
sleep homeostat remains to be defined. The function of the core
clock transcription factors CLOCK, NPAS2, and BMAL1 resides
in their hetero-dimerization and binding to E-box (CANNTG) or
E-box like (E’-box) elements of target genes from which
transcription is initiated [5,6]. Some specific targets such as Period
(Per)-1, and -2, and Cryptochrome (Cry)-1, and -2 genes subsequently
provide negative feedback by interfering with the CLOCK::
BMAL1 or NPAS2::BMAL1 transcriptional complexes thereby
inhibiting their own transcription [4]. In addition, other target
genes such as the orphan nuclear receptor families Rev-Erb and
Ror, respectively suppress and promote the expression of Npas2,
Bmal1, and Cry1. These feedback loops, in combination with
diverse post-translational mechanisms, result in a rhythmic (about
24 h) expression of clock genes, of their protein product, and of a
number of output genes (or clock controlled genes) governing a
multitude of physiological functions.
It was initially reported that rhythmic gene expression did not
depend on rhythmic binding of CLOCK and BMAL1 to the E-
box element of a target gene, that of Per1 in particular [7]. More
recent reports clearly demonstrate, however, that CLOCK and
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BMAL1 bind to clock genes, notably to Per1, Per2, Cry1, Cry2, and
Dbp (D site albumin promoter binding protein), in a time-of-day
dependent manner in the mouse liver [6,8–10]. Similar observa-
tions of rhythmic chromatin binding were reported also for the
core clock transcription factors CLOCK and CYCLE in the fruit
fly, where they were shown to contribute to rhythmic gene
expression [11–13]. These data imply that, at least for some clock
genes, changes in binding of the core clock transcription factors to
their genomic sequence play a role in the circadian modulation of
their expression.
Work from our group and that of others demonstrate that, in
addition to their well established role in generating circadian
rhythms, clock genes also play a circadian-independent role in
sleep homeostasis [14]. First, mutations in some clock gene change
the electroencephalographic (EEG) and molecular markers of
sleep pressure in mice [15–19]. For instance, Npas22/2 mice show
an attenuated EEG delta power response to sleep deprivation
(SD), revealed between 1 and 2 Hz, compared to wild-type
littermates [19], whereas this marker of sleep intensity is greatly
increased during normal sleep in Cry1,22/2 double-knockout mice
[16]. Second, an increase in sleep pressure achieved by SD
changes the expression of several clock genes in the forebrain of
various inbred mouse strains, notably that of Per1, Per2 and Dbp
[16,20,21]. Moreover, although we found that in the mouse some
of these sleep/wake-dependent changes, especially those of Per1
and Per3, were driven by the corticosterone surge associated with
the SD, the increase in Per2 expression and the decrease in Dbp
expression were largely independent of corticosterone [22]. This
last finding suggests that the SD-induced changes in the expression
of these two clock genes are likely caused by modifications in the
activity of the core clock transcription factors (i.e., CLOCK,
NPAS2, and BMAL1) upon their respective promoter. The fact
that the increase in Per2 in the brain is reduced in Npas22/2 mice
[19] and increased in Cry1,2 double KO mice [21] further
supports such notion.
We here investigate the potential role of changes in DNA
binding activity of core clock transcription factors in the
modulation of clock gene expression observed with elevated sleep
pressure. Specifically, we hypothesize that SD modifies the binding
of clock transcription factors to the E-box and/or E’-box
sequences of specific clock genes, especially that of Per2 and Dbp,
in the mouse cerebral cortex. Using chromatin immunoprecipi-
tation (ChIP) of cortical tissue, we first observed that the binding of
clock transcription factors to several clock genes depended on
time-of-day in the mouse cortex in a way comparable to the time
course previously described for liver [6,9,10]. Importantly, we
found that SD alters the binding of clock transcription factors to
their target genes. This effect was both transcription factor and
target gene specific. Our findings thus reveal that sleep pressure, in
addition to internal time-of-day, can modify the DNA-binding
properties of core clock proteins in the brain, providing a
mechanism by which clock components can sense homeostatic
sleep need.
Results and Discussion
Rhythmic binding of BMAL1 and CLOCK to selected clock
genes
We have previously shown that SD does not uniformly affect the
expression of all clock genes in the brain [16,19–23]. For the
present chromatin binding study, we selected Cry1 which shows
either no change or a small amplitude decrease or increase
following SD, Dbp for which mRNA consistently decreases after
SD, and Per1 and Per2 which mRNA are increased by SD. To
validate our technique, we first confirmed rhythmic binding of
CLOCK and BMAL1 to the E-box or E’-box elements of the
promoter of the four selected clock genes in the mouse liver. Livers
collected at 4 different times of day (ZT0, 26, 212, and 218)
were processed using ChIP. Consistent with the literature [6,8–
10], we observed that the binding of BMAL1 and CLOCK to Cry1
and Dbp was higher at ZT6 (i.e., 6 h after lights on) than at ZT18
(i.e. 6 h after lights off) or ZT0 (Figure 1). A similar phase was
observed for BMAL1 and CLOCK binding to Per1 and Per2
promoters (Figure 1).
Daily changes in chromatin binding of core clock transcription
factors to the target genes of interest have not been assessed in the
mammalian brain. Therefore, and to put the eventual changes
incurred by the SD into context (see below), we determined the
time-of-day variations in DNA-binding of BMAL1 and CLOCK
to the four selected clock genes in the mouse cerebral cortex.
Cortical tissue from the same 4 different times of day (ZT0, 26,
212, and 218) were analyzed using ChIP. The binding of both
core clock transcription factors to their four target genes exhibited
highly similar time-of-day variations (Figure 2). Specifically,
CLOCK bound to the four target genes in a time-of-day-
dependent manner with maximum binding reached at ZT6 and
lowest binding at ZT18 or -0 for Cry1 (one-way ANOVAs:
F3,48 = 3.9, p = 0.01), Dbp (F3,49 = 6.8, p,0.001), and Per2
(F3,59 = 4.6, p,0.01), while the binding to Per1 peaked at ZT12
and reached a minimum at ZT18 (F3,54 = 3.8, p,0.02). BMAL1
binding showed a similar pattern with maximal levels reached at
ZT6 and a minimum at ZT18- or -0 for Cry1 (F3,56 = 4.3, p,0.01)
and Dbp (F3,56 = 2.9, p,0.05), whereas, although similar, the time-
of-day changes in Per1 and Per2 binding did not reach statistical
significance (F3,60 = 1.7, p = 0.2, n.s. for Per1; F3,67 = 2.2, p = 0.09,
n.s. for Per2).
We here demonstrate, for the first time, that in the cerebral
cortex, the binding of BMAL1 and CLOCK to the targeted clock
genes varies in function of time of day. These observations are
similar to the only other study having assessed BMAL1 binding in
the mouse brain [24], which showed a higher binding of BMAL1
to the clock gene Rev-Erba and to Maoa at ZT6 than at ZT18. Our
data, in particular for Cry1 and Dbp, are also consistent with the
observations made in the liver where ChIP for BMAL1 and
CLOCK also resulted in a higher level of amplified Cry1 and Dbp
promoters at ZT6 compared to ZT18 [6,8–10]. The phase
positions of maximum and minimum RNA levels are similar
between the brain and liver for the different transcripts targeted
(Figure 4 for a review). Therefore, for each target, similar DNA-
binding rhythms between the two tissues were expected. We
observed a similar phase regarding the binding of clock
transcription factors to Per1 and Per2 promoters in the cortex.
This rhythm seemed, however, less robust as it did not reach
statistical significance for BMAL1. In the liver, one study showed
that BMAL1 and CLOCK binding to Per1 promoter did not vary
with time-of-day [7], while another study indicated an inverse
phase for Per2 binding by CLOCK (i.e., higher at ZT15 than at
ZT6) although binding was not quantified [25]. A recent study
indicates, however, that BMAL1 binding to both Per1 and Per2 in
the mouse liver appears to peak at ZT6 [10], similar to our
findings in the cortex. In the fruit fly, a highly rhythmic binding of
CLOCK to Per, with a peak centered around ZT12, was reported
and was shown to be closely linked to the rhythm of Per mRNA
levels [11–13]. Given the variable results obtained in mice for
DNA-binding to Per1 and Per2, it is possible that transcriptional
rhythms of mammalian Per genes depend less on a highly rhythmic
DNA-binding of CLOCK and BMAL1 compared to those of Cry1
and Dbp or that of Per in Drosophila.
Sleep and Clock Transcription Factors Activity
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Sleep deprivation decreases BMAL1, CLOCK, and NPAS2
binding to specific clock genes
To assess the effect of sleep loss on the binding activity of core
clock transcription factors to the targeted clock genes, we
measured the impact of a 6 h SD performed between ZT0 and
26 on the binding of BMAL1 and CLOCK to the promoter of
clock genes in the mouse cerebral cortex (Figure 3). We observed
that SD specifically decreased the binding of BMAL1 to the
promoter of Dbp and Per2 (t-tests: t =23.0, p,0.01 and t =23.7,
p,0.01, respectively), whereas binding to Cry1 and Per1 genes was
not affected by SD (p.0.5, n.s.). The binding of CLOCK to Dbp
was also significantly decreased by SD (t =22.2, p = 0.05) while
CLOCK binding to the other clock genes assessed (i.e., Cry1, Per1,
and Per2) was not affected (p$0.5, n.s.).
Since BMAL1 binding to Per2 and not that of CLOCK was
decreased by SD, we hypothesized that the SD-mediated change
in BMAL1 binding on the promoter of Per2 could be mediated by
the interaction of BMAL1 with its alternative partner, NPAS2.
NPAS2, a CLOCK homolog, can associate with BMAL1 and
perform a similar role in regulating clock genes transcription [26].
In addition, NPAS2 is predominantly expressed in the brain,
particularly in the cerebral cortex and thalamus [27], and was
shown to be involved in the response to SD including the increase
in EEG slow waves, in NREM sleep duration, and in Per2 mRNA
[19]. We therefore also quantified the effect of SD on the binding
of NPAS2 to the chromatin of clock genes in the mouse cerebral
cortex (Figure 3, right grey columns). We observed that SD
significantly decreased the binding of NPAS2 to Per2 (t =24.6,
Figure 1. The effect of time-of-day (ZT) on BMAL1 and CLOCK binding onto the promoter of 4 clock genes in the mouse liver. Mice
were sacrificed every 6 hours for 24 hours (ZT0= Lights ON), and livers were rapidly sampled and processed. Chromatin immunoprecipitation (ChIP)
was performed using antibodies against BMAL1 and CLOCK, and enrichment of E-box or E’-box containing sequences of the putative promoter
region of Cry1, Dbp, Per1, and Per2 was measured using quantitative PCR. Data were normalized to a negative control condition (no-antibody). Time-
of-day significantly affected the binding of BMAL1 (F3,19 = 4.3, p,0.05) and that of CLOCK (F3,21 = 4.1, p,0.05) to Cry1. Similar trends were also
observed regarding binding to Dbp (BMAL1: F3,19 = 2.4, p = 0.1, n.s.; CLOCK: F3,19 = 2.7, p = 0.08, n.s.) and CLOCK binding to Per1 (F3,21 = 2.0, p = 0.1,
n.s.). Data are presented as mean6 SEM (n= 5, 5, 5, 5 for all genes for BMAL1; Cry1 n= 5, 6, 5, 6; Dbp and Per2 n= 5, 5, 5, 5; Per1 n= 6, 6, 5, 5 for CLOCK
for ZT0, 26, 212, and 218, respectively). Grey lines connect double-plotted data, and light grey areas represent 12 h dark periods. (*: p#0.05
between indicated points; post-hoc Tukey comparisons).
doi:10.1371/journal.pone.0026622.g001
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p,0.01). A similar tendency was observed regarding the binding
of NPAS2 to Dbp (t =22.2, p,0.07, n.s.), while, again, no change
in NPAS2 binding to Cry1 and Per1 genes was observed (p.0.2,
n.s.).
We thus revealed that elevated sleep pressure changes the
binding of the three core clock transcription factors (i.e., BMAL1,
NPAS2, and CLOCK) to specific clock genes. As expected,
significant SD-dependent changes in DNA binding were observed
only for Dbp and Per2, the two clock genes showing a response
mostly independent of the glucocorticoids surge associated with
SD [22]. Regarding the DNA binding to Cry1, the observed
absence of changes following SD is consistent with the lack of a
clear SD effect upon Cry1 mRNA expression. Also for Per1, we did
not observe a change in DNA binding following SD although SD
clearly increases Per1 expression in the mouse brain [16,20,22,23].
We recently showed that this SD-induced increase in Per1
expression is mediated through a surge in glucocorticoids [22],
which combined with the present observations suggest that
changes in Per1 expression following SD are largely due to
modifications in its transcription via the activation of a
glucocorticoid-response element (GRE) present in its promoter
[28], and not through activation involving the core clock
components.
Our results specifically show that SD decreases the binding of
CLOCK, NPAS2, and BMAL1 to Dbp in the mouse brain. Since
we previously observed that the SD-dependent decrease in Dbp
Figure 2. The effect of time-of-day (ZT) on BMAL1 and CLOCK binding onto the promoter of 4 clock genes in the mouse cerebral
cortex. Mice were sacrificed every 6 hours for 24 hours (ZT0=Lights ON), and cerebral cortices were rapidly sampled and
processed. Chromatin immunoprecipitation (ChIP) was performed using antibodies against BMAL1 and CLOCK, and enrichment of E-box or E’-box
containing sequences of the putative promoter region of Cry1, Dbp, Per1, and Per2 was measured using quantitative PCR. Data were normalized to a
negative control condition (no-antibody). Time-of-day significantly affected the binding of BMAL1 to Cry1 and Dbp genes, and the binding of CLOCK
to all 4 target genes. Data are presented as mean6 SEM (Cry1 n=14, 16, 14, 13; Dbp n= 14, 15, 13, 15; Per1 n= 16, 16, 14, 15; Per2 n= 16, 18, 17, 17 for
BMAL1; Cry1 n=13, 13, 12, 11; Dbp n= 12, 14, 11, 13; Per1 n= 15, 14, 12, 14; Per2 n= 14, 15, 15, 16 for CLOCK for ZT0,26,212, and218, respectively).
Grey lines connect double-plotted data, and light grey areas represent 12 h dark periods. (*: p#0.05 between indicated points; post-hoc Tukey
comparisons).
doi:10.1371/journal.pone.0026622.g002
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expression was not affected by the glucocorticoid surge [22], and
since core clock transcription factors are known to be the main
transcriptional regulators of Dbp [6,10], the decreased binding of
BMAL1 and CLOCK, and to some extent also that of NPAS2,
might be sufficient to explain the decrease in Dbp expression after
SD. However, the present findings cannot exclude the contribu-
tion of other pathways in mediating the SD-dependent decrease in
Dbp expression. For instance, TNFa was recently shown to
decrease Dbp expression via a TNFR1 and calcium-dependent
pathway [29]. These authors also showed that TNFa could
increase Per1 expression, which could contribute, in combination
with a GRE-mediated response [22], to the SD-dependent
increase in Per1. The TNFa pathway is relevant to sleep regulation
as reduced sleep duration was associated with increased TNFa in
humans and rodents [30,31], and inactivation of TNFa or
TNFR1/IL1R1 alters sleep amounts and EEG [32,33]. Hence,
core clock transcription factors are most likely not the sole
contributors to the SD-dependent changes in clock gene
expression, and future studies aiming at assessing the SD-
dependent changes in clock gene expression in animals bearing
mutations of core clock transcription factors will be required to
understand their specific contribution.
The observation of a SD-dependent decrease in NPAS2 binding
and a lack of effect of SD upon CLOCK binding on Per2 was
unexpected given the overlapping roles of CLOCK and NPAS2 in
the maintenance of circadian rhythmicity in behavior and gene
expression [26,34]. In peripheral tissues, referring here to non-
suprachiasmatic nucleus tissues, the presence of CLOCK was
shown, however, to be required for the persistence of rhythmic
gene expression [35]. The sequence of CLOCK and NPAS2 are
similar except for the presence of an extra 43 aa. at the carboxy
end of CLOCK. In addition, NPAS2 also lacks an acetyl-CoA
binding motif (aa. 656–664) and a poly-glutamine sequence (aa.
753–776) compared to CLOCK. The acetyl-CoA binding motif
has been involved in conferring CLOCK with a histone
acetyltransferase (HAT) activity [36]. These sequence differences
might prevent elevated sleep pressure from changing CLOCK
binding to Per2, whereas allowing it for Dbp. This indicates that,
within the same tissue, the effect of elevated sleep pressure on clock
gene expression involves complex and different patterns of
transcriptional regulation which are highly specific to each clock
gene.
We observed that the increase in Per2 expression following SD
[16,20,22,23] was accompanied by a decrease in binding of
BMAL1 and NPAS2 to its promoter, which seems paradoxical. It
could be argued that the SD-dependent increase in Per1 and Per2
mRNA followed by an increase in protein [45] would not initially
be driven by BMAL1::CLOCK/NPAS2 but rather, among
others, through glucocorticoids::glucocorticoid receptor binding
to GRE and/or CREB (cAMP response element binding protein)
binding to CRE [37], another pathway that has been linked to
sleep regulation [38]. Subsequently, increase in nuclear PER2
could decrease the DNA binding activity of core clock transcrip-
tion factors and subsequently mRNA levels of their target genes
like Dbp. This possibility is supported by our observation that Per1
and Per2 mRNA levels are increased as early as after 1 h of SD
whereas the Dbp decrease occurs after 3 to 6 h of SD [20]. To
address this possiblity, the detailed time course of core clock
transcription factors binding and of glucocorticoid receptors
binding to the target DNA regions of Per1 and Per2 and their
relation to nuclear levels of PER1 and PER2 protein levels will
need to be assessed over the course of SD. To further complicate
matters, BMAL1 and CLOCK were recently shown to be able to
repress glucocorticoids-mediated transcription [39].
Core clock transcription factor binding and
transcriptional activation
To clarify the link between DNA binding and mRNA levels, we
examined the relationship between the two in the mouse liver and
brain. We first observed that during the time when SD is usually
performed (i.e., between ZT0 and 26), the binding of BMAL1
and CLOCK to all clock genes assessed gradually increases during
control conditions when animals are mainly asleep (Figures 1 and
2). Increased DNA-binding during this time is not always linked to
a mRNA increase of the corresponding gene. For instance, while
the expression of Dbp is increasing during that interval, the mRNA
levels of Cry1, Per1, and Per2 are decreasing [20,23]. The current
literature indeed supports a range of phase relationships between
the two rhythms (Figure 4). For Cry1, the peak in chromatin
binding is in antiphase with the peak in mRNA levels for both liver
and cortex (about 12 h apart). This contrasts the data regarding
Dbp for which the peak in chromatin binding and mRNA
expression coincide. Regarding Per1 and Per2, there is a phase
delay of about 6 h such that when BMAL1 and CLOCK binding
begins to decrease, the mRNA levels reach their peak. These
observations are consistent with a recent report that assessed both
the time-of-day rhythm of BMAL1 binding to these clock genes
and the mRNA expression rhythms in the mouse liver [10].
Accordingly, elevated or decreased BMAL1 and CLOCK DNA-
binding are not directly linked to increased or decreased mRNA
levels, respectively, and this seems especially true for Cry1, Per1,
and Per2, and in both the cerebral cortex and liver.
Previous work described several molecular mechanisms likely to
contribute to the delay between chromatin binding and gene
expression. For instance, it has been suggested that the phase of
Figure 3. The effect of sleep deprivation (SD) on BMAL1,
CLOCK, and NPAS2 binding onto the promoter of 4 clock
genes in the mouse cerebral cortex. SD was performed between
ZT0 and 26 after which cerebral cortices were rapidly sampled and
processed together with non-sleep deprived controls. Chromatin
immunoprecipitation (ChIP) was performed using antibodies against
BMAL1, CLOCK, and NPAS2, and enrichment of E-box or E’-box
containing sequences of the putative promoter regions of Cry1, Dbp,
Per1, and Per2 was measured using quantitative PCR. Data were
normalized to a negative control condition (no-antibody) and expressed
relative to the control non-sleep deprived sample performed in parallel.
SD significantly decreased the binding of BMAL1 to Dbp and Per2, the
binding of CLOCK to Dbp gene, and the binding of NPAS2 onto Per2.
Data are presented as the mean SD/control percentage ratio (6 SEM of
the ratio; n = 18, 17, 16, 14 for BMAL1; n = 10, 10, 9, 8 for CLOCK; n = 9, 8,
8, 6 for NPAS2 for Cry1, Dbp, Per1, and Per2, respectively). Please note
logarithmic scaling of y-axis (+: p,0.07, *: p = 0.05, **: p,0.01; t-tests).
doi:10.1371/journal.pone.0026622.g003
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Figure 4. Overview of the phase relationship between RNA expression and chromatin binding. Time-of-day or circadian variations in
mRNA expression for the selected clock genes (i.e., Cry1, Dbp, Per1, and Per2) for liver and brain samples from selected literature together with
variations in DNA-binding of CLOCK (C) and BMAL1 (B) onto these clock genes shown from all previous literature in mice (i.e., liver) and the present
study [6–10,45,62–75]. Relative heat scales go from blue (minimum) to red (maximum). ZT: Zeitgeber time with ZT12= dark onset; CT: Circadian time
with CT12 = activity onset. For Cry1, RNA expression and DNA-binding seem to be in antiphase for both liver and brain, whereas the two rhythms are
always in-phase for Dbp. Regarding Per1 and Per2, the peak in DNA-binding precedes by several hours that of RNA expression for both tissues.
doi:10.1371/journal.pone.0026622.g004
Sleep and Clock Transcription Factors Activity
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some transcripts is due to the interplay between several different
transcriptional regulators acting on their promoter [40]. Similarly,
Rey et al. [10] proposed that the higher the dependence on
BMAL1 transcriptional regulation, the smaller the time lag
between chromatin binding and gene expression. In particular,
REV-ERBa could prevent the recruitment of RNA polymerase II
to the Cry1 promoter at CT6, thereby interfering with CLOCK::-
BMAL1 transcriptional activation [8]. Furthermore, the
CLOCK::BMAL1 complex itself was shown to repress Cry1 gene
expression when CRY1 bound to the complex [41]. In Drosophila,
the regulation of Per and Tim expression was shown to depend on
the delicate balance between the binding of CLOCK and that of
the repressor PER [13], which was suggested to drive two phases
of repression: an ON-DNA phase and an OFF-DNA phase. Also
other regulators such as the repressor DEC1, can affect Per
expression [42]. Such mechanisms might be relevant to our
observation of a decreased binding to Per2 simultaneous to an
increased mRNA level after SD, and stress the complex
transcriptional regulation of clock genes by clock elements in
addition to their regulation by non-clock elements (see above).
Also, chromatin state importantly contributes to the relationship
between DNA-binding and transcriptional activation as transcrip-
tion is possible only when chromatin is in a permissive
configuration. As mentioned earlier, CLOCK is a HAT required
for rhythmic expression of Dbp and Per1 independent of DNA-
binding [36]. Furthermore, MLL1, a histone methyltransferase,
was recently identified as a protein partner of CLOCK and an
essential component to both Dbp and Per2 rhythmic expression
[43]. These mechanisms are likely to contribute also to the highly
specific transcriptional regulation of individual clock genes. This
specificity seems to be similarly reflected at the level of the so-
called circadian and the sleep pressure-dependent changes, since
the various phase relationships between rhythms of chromatin
binding and gene expression (antiphase, in-phase, delayed) are also
linked to a specific response to SD in terms of mRNA levels (Cry1
no distinct change, Dbp decrease, Per genes increase, respectively)
and core clock transcription factor binding.
In the present study, the effect of SD on DNA binding was
assessed at the time when the binding of core clock transcription
factors peaks (i.e., ZT6; Figure 2). This could have biased our
results towards emphasizing decreases in binding as opposed to
increases. To address this issue one could assess the effects of SD
on DNA-binding at different circadian phases. Moreover, it is
possible that the SD protocol could have shifted the phase of core
clock transcription factors binding to the DNA of their specific
targets, namely that of Dbp and Per2. This could occur either
through a direct effect of wakefulness on the cerebral cortex
molecular clock machinery or via resetting of the suprachiasmatic
nucleus clock, which was shown to respond to behavioral
stimulation (arousal and locomotor activity) [44]. Along this line,
it is of interest to note that the main normal waking episode in
mice, occurring between ZT12 and218, is also accompanied by a
decrease in Per2 DNA binding by clock transcription factors and
increased levels of Per2 mRNA (Figure 4). Thus, the distribution of
sleep and waking under baseline conditions might contribute to
the so-called circadian changes in DNA-binding and gene
expression in the mouse brain as we recently modeled in detail
[45].
Perspectives and conclusions
Neuronal plasticity and neuroprotection are among the
functions likely to be direct correlates of sleep need [22,23,46].
Clock genes have been shown to be involved in plasticity,
particularly Per genes and Npas2 [47,48]. For example, impaired
hippocampal LTP was observed in Per2 mutant mice [49], and
decreased long-term memory of courtship and waking experience-
dependent increase in sleep in Per mutant flies [50,51]. Therefore,
clock genes could modulate cortical synchrony and synaptic
equilibrium associated with vigilance states, which is further
illustrated by the effect of clock-gene mutations on sleep
homeostasis [14]. Combining ChIP with high throughput
sequencing of cerebral cortex sampled either after sleep or SD
could help to identify further targets of BMAL1 and CLOCK/
NPAS2 relevant to synaptic plasticity.
The transcriptional response to SD depends on brain area
[52,53]. Also the change in Per expression after SD was shown to
express a characteristic neuroanatomical pattern, with elevated
sleep pressure producing more pronounced increases in the
cerebral cortex [20,21]. In the present study, the SD-dependent
changes in chromatin binding were specifically assessed in the
cerebral cortex to more closely investigate their role in the
recovery aspect of sleep which is known to be linked to EEG
activity in slow frequencies [3,46]. Nonetheless, the role of clock
genes could extend to other, non-cortical brain areas. Also, we
measured the binding of BMAL1, CLOCK, and NPAS2 to a
single E/E’-box containing sequence. It is believed that the
number of different E/E’-box containing sites bound by those
transcription factor complexes within a gene will strengthen
transcriptional control [10]. Accordingly, characterization of the
SD effect upon binding to several sites in the promoter and
intronic regions of our genes of interest will be useful to clarify the
detailed molecular mechanisms governing SD-dependent changes
in clock genes expression.
In conclusion, we reported that in the mouse cerebral cortex,
core clock transcription factors bind to the DNA of target clock
genes in function of time-of-day. Moreover, we revealed that
extended wakefulness changes the binding of core clock transcrip-
tion factors to the promoter of specific clock genes; specifically, SD
decreased CLOCK binding to the promoter of Dbp, and decreased
BMAL1 and NPAS2 binding to Per2 and Dbp. These sleep-wake
dependent changes in DNA-binding are likely contributing to the
observed alterations in gene expression following SD, and also to
changes observed with time-of-day. Together, our data further
support a role for clock genes in the homeostatic regulation of
sleep. An avenue we are currently following up on, is how elevated
sleep pressure changes the multi-clock protein complex associated
to the BMAL1::CLOCK/NPAS2 dimers. Also, future research
studying the link between clock genes and sleep homeostasis
should focus on the involvement of post-translational modifica-
tions, for instance on the acetylation status of the core clock
proteins that was shown to tightly regulate their function [54,55].
Materials and Methods
Animals and protocol
C57BL/6J mice originally purchased from Jackson Laboratory
(Bar Harbor, ME, USA) were bred on site and maintained under
standard animal housing conditions (free access to food and water,
12h-light/12h-dark cycle, 23uC ambient temperature). Males
between 11 and 15 weeks at the time of the experiments were
used in this study. For the time-of-day experiment, mice were
sacrificed at ZT0 (Zeitgeber time 0: lights ON), ZT6, ZT12 (lights
OFF), and ZT18 by cervical dislocation and the liver and cerebral
cortex were immediately removed and fixed (within 1 min), and
processed for chromatin extraction. For the sleep deprivation (SD)
experiment, mice were sleep-deprived for 6 h starting at ZT0 by
gentle handling [56], and sacrificed at ZT6 together with non-
sleep-deprived controls. Cerebral cortices were immediately
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sampled, fixed and processed for chromatin extraction. Experi-
ments were performed with 2 to 4 animals per time (ZT) or
condition (SD vs. control), independently repeated 4 to 6 times,
and samples were processed randomly. Ethics statement: All
experiments were approved by the Cantonal Veterinary Office
of Vaud.
Chromatin immunoprecipitation (ChIP)
Chromatin extraction and immunoprecipitation was performed
with the Magna ChIP G commercial kit (Millipore Corporation,
Billerica, MA, USA) according to the manufacturer’s instructions.
Briefly, cortices were chopped in small pieces and incubated for
10 min in 1% formaldehyde followed by a 5 min glycin-
quenching. After washes and cellular and nuclear lysis, chromatin
breakdown was performed with a Bioruptor UCD-200TO
(Diagenode SA, Lie`ge, Belgium) to achieve a range of 300–
1000 bp chromatin lengths as determined by ethidium bromide
agarose gel electrophoresis (cycles 30 sec ON-30 sec OFF at
maximum intensity for 15 min). A pre-clear step was performed
(1 h at 4uC with 40 ml of magnetic beads) before overnight
incubation of chromatin and beads with antibodies. Anti-BMAL1
antibody was from Abcam (Cambridge, England, product
#ab3350), and anti-CLOCK from Abcam (product #ab461) or
Santa Cruz Biotechnologies (product #sc-6927). These commer-
cial antibodies have been used by independent groups for
circadian rhythm research including for ChIP [57–59]. Custom
anti-NPAS2 antibodies were produced from rabbit immunization
using a peptide directed against amino acids 796 to 810 of the C-
terminal domain of NPAS2 (accession #NP_032745) by Lucerna-
Chem AG (Lucerne, Switzerland). The specificity of this antibody
was verified by ELISA and Western blot on brain protein extracts
(91 kDa). All samples were also identically submitted to a no-
antibody condition (mock condition) used to take into account
nonspecific binding. DNA purification was performed using the
silica columns provided with the kit (Magna ChIP G, Millipore).
Quantitative PCR
Quantitative PCR (qPCR) was performed according to Applied
Biosystems protocol using a 7900HT Fast Real-time PCR System
with SDS2.3 software (Applied Biosystems, Foster City, CA, USA).
For each qPCR reaction, purified immunoprecipitated DNA was
slightly diluted (4/5) and mixed with 0.9 mM of each primers,
0.25 mM of probe and MasterMix reagent (Applied Biosystems) or
FastStart Universal Probe Master (Roche Diagnostic GmbH,
Mannheim, Germany). The qPCR was performed under standard
cycling conditions (i.e., 95uC for 10 min, followed by 45 cycles of
95uC for 15 sec and 60uC for 1 min). Each qPCR reaction was
done in triplicate. Primers and probes were designed with Primer
Express v2.0 (Applied Biosystems) to amplify E-boxes and E’-boxes
containing genomic regions of the four target clock genes (Cry1,
Dbp, Per1 and Per2). More precisely, the amplicons targeted
functional sequences located in the promoter region: most
proximal E-box (CACGTG) and E’-box (CACGTT) of Cry1
(similar to [8], same as [60]), the most proximal E-box (CATGTG)
of Dbp [6], the first E-box (CACGTG) of Per1 [5,37], and two E-
boxes (CAGATG, CATTTG) of Per2 [37]. As an additional
negative control, an amplicon targeting a non-CLOCK::BMAL1
target (i.e., exon 5 of Pmp22) was also amplified for liver samples
and for half of cortical samples (Figures S1 and S2). The
oligonucleotide sequences and their source are provided in
Table 1. Primers were purchased from Invitrogen or Microsynth
(Balgach, Switzerland) and probes from Eurogentec SA (Seraing,
Belgium).
Statistical analysis
Tissue sampled from each animal was treated separately and
data from the repeated experiments were combined. Similar to
what was performed previously [6,8–10], binding was initially
analyzed as a fold relative to input chromatin (Figure S1 for liver
and Figure S2 for cerebral cortex). However, we observed that
non-specific binding (no-antibody condition) varied and was
influenced by time-of-day for liver (Figure S1 legend). Thus, data
were expressed in fold-change relative to the no-antibody negative
control condition, as performed in other studies [12,61], in order
to control for non-specific binding and also for between-
experiment differences. The number of biological replicates (i.e.,
the number of individual mice) contributing to each data point is
indicated in each figure. Numbers vary because of data loss and
removal of outliers; i.e., values more than two standard deviations
away from the mean (,6% of all values). Fold enrichments were
calculated as a ratio of the power of Ct between sample and the
respective no-antibody control (i.e., fold enrichment = [2ˆ(- Ct
sample)]/[2ˆ(- Ct no-antibody)]). The effect of time-of-day on
chromatin binding was assessed by one-way ANOVA, and
significant effects were decomposed using Tukey tests. For
assessing the SD effect on chromatin-binding, between-experiment
differences were taken into account by expressing each SD
enrichment level in percent of the enrichment level of a non-sleep
deprived control processed in the same batch ([fold enrichment
Table 1. Primers and probes used for qPCR.
Gene Forward (59 –.39) Reverse (59 –.39) Source
Cry1 CCCCGGCTTCTCATTGG CAGTGTAGTAAACACACTTCAGAAACGT NCBIM37:10:84593000:84647800:1
probe FAM-CCCCACGTGACCACCGGCA-BQH
Dbp ACACCCGCATCCGATAGC CCACTTCGGGCCAATGAG NCBIM37:7:52959000:52965561:1
probe FAM-CGCGCAAAGCCATGTGCTTCC-TAMRA (see Ripperger and Schibler, 2006)
Per1 AGCTTTAGCCACGTGACAGTGA GGCAAGTGAAGAGGCCAACA AB030818
probe FAM-TGCACTTAACAGCTGATTATGTCAGCCGC-BHQ
Per2 AGAAAAGCCCTGCTGTTCCA CCAAATGCGGTGGTGTAGTTT AF491941
probe FAM-CCGCTTCCATAGTTCCTGTAAGGT-BQH
Pmp22 TTCGTCAGTCCCACAGTTTTCTC ACTCGCTAGTCCCAAGGGTCTA NM_008885
probe FAM- CGGTCGGAGCATCAGGACGAGC-BHQ
doi:10.1371/journal.pone.0026622.t001
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SD/fold enrichment control]*100). The effect of SD was then
analyzed using two-tailed single sample t-tests. Statistical analyses
were performed with GraphPad Prism 4 (GraphPad Software Inc.,
San Diego, CA) or Statistica (Statsoft Inc., Tulsa, OK). The
threshold for statistical significance was set to,0.05 and results are
reported as mean 6 SEM.
Supporting Information
Figure S1 BMAL1 and CLOCK binding onto the pro-
moter of 4 clock genes in the mouse liver. Mice were
sacrificed every 6 hours for 24 hours, and livers were rapidly
processed. Chromatin immunoprecipitation (ChIP) was performed
using antibodies against BMAL1 and CLOCK or no antibody
(negative control), and enrichment of putative promoter sequences
of Cry1, Dbp, Per1 and Per2, and of a non-CLOCK::BMAL1 target,
Pmp22, was measured using quantitative PCR. Data were
expressed relative to input DNA. Time-of-day affected non-
specific binding (no antibody) to Cry1 (F3,23 = 4.2, p,0.05), Dbp
(F3,22 = 3.9, p,0.05), and Per1 (F3,22 = 3.9, p,0.05, all plotted in
both BMAL1 and CLOCK columns), but not that of BMAL1 or
CLOCK to the control gene Pmp22. Data are presented as mean
6 SEM. Grey lines connect double-plotted data, and light grey
areas represent 12 h dark periods.
(TIF)
Figure S2 BMAL1 and CLOCK binding onto the pro-
moter of 4 clock genes in the mouse cerebral cortex.Mice
were sacrificed every 6 hours for 24 hours, and brain cortices were
rapidly processed. Chromatin immunoprecipitation (ChIP) was
performed using antibodies against BMAL1 and CLOCK or no
antibody (negative control), and enrichment of putative promoter
sequences of Cry1, Dbp, Per1 and Per2, and of a non-CLOCK::-
BMAL1 target, Pmp22, was measured using quantitative PCR.
Data were expressed relative to input DNA. Time-of-day did not
significantly affect non-specific binding (no antibody), neither that
of BMAL1 or CLOCK to the control gene Pmp22. Data are
presented as mean 6 SEM. Grey lines connect double-plotted
data, and light grey areas represent 12 h dark periods.
(TIF)
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